Adicet Bio, Inc. Quarterly Operating Income (Loss) in USD from Q1 2017 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Adicet Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2017 to Q3 2024.
Adicet Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$33.2M, a 36.6% increase year-over-year.
Adicet Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$128M, a 15.5% increase year-over-year.
Adicet Bio, Inc. annual Operating Income (Loss) for 2023 was -$152M, a 110% decline from 2022.
Adicet Bio, Inc. annual Operating Income (Loss) for 2022 was -$72.6M, a 18.1% decline from 2021.
Adicet Bio, Inc. annual Operating Income (Loss) for 2021 was -$61.4M, a 56.8% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	-$128M	-$33.2M	+$19.1M	+36.6%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-06
Q2 2024	-$148M	-$32.8M	+$2.04M	+5.85%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	-$150M	-$30.9M	+$2.45M	+7.36%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	-$152M	-$31.6M	+$1K	+0%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-19
Q3 2023	-$152M	-$52.3M	-$29.3M	-127%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-06
Q2 2023	-$123M	-$34.9M	-$12.2M	-53.7%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-13
Q1 2023	-$111M	-$33.3M	-$38M	-808%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-14
Q4 2022	-$72.6M	-$31.6M	-$16M	-103%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-19
Q3 2022	-$56.5M	-$23M	-$9.28M	-67.7%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-08
Q2 2022	-$47.3M	-$22.7M	-$11.9M	-110%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-09
Q1 2022	-$35.4M	$4.71M	+$26.1M		Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-09
Q4 2021	-$61.4M	-$15.5M	-$6.19M	-66.2%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-15
Q3 2021	-$55.2M	-$13.7M	-$55K	-0.4%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-08
Q2 2021	-$55.2M	-$10.8M	-$2.2M	-25.5%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-10
Q1 2021	-$53M	-$21.4M	-$13.8M	-183%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	-$39.2M	-$9.35M	+$20.1M	+68.2%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-15
Q3 2020	-$59.3M	-$13.7M	+$1.57M	+10.3%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	-$60.8M	-$8.63M	+$10.5M	+55%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020	-$71.4M	-$7.56M	+$4.13M	+35.4%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-17
Q4 2019	-$75.5M	-$29.4M	-$23.1M	-363%	Oct 1, 2019	Dec 31, 2019	10-K	2020-03-12
Q3 2019	-$52.4M	-$15.2M	-$6.19M	-68.6%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019	-$46.3M	-$19.2M	-$5.06M	-35.8%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-07-31
Q1 2019	-$41.2M	-$11.7M	-$1.49M	-14.6%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	-$39.7M	-$6.36M	+$1.16M	+15.5%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-12
Q3 2018	-$40.9M	-$9.03M	-$5.09M	-129%	Jul 1, 2018	Sep 30, 2018	10-K	2020-03-12
Q2 2018	-$35.8M	-$14.1M	-$10.1M	-248%	Apr 1, 2018	Jun 30, 2018	10-K	2020-03-12
Q1 2018	-$25.7M	-$10.2M	-$6.84M	-204%	Jan 1, 2018	Mar 31, 2018	10-K	2020-03-12
Q4 2017	-$18.9M	-$7.52M			Oct 1, 2017	Dec 31, 2017	10-K	2019-03-18
Q3 2017		-$3.95M			Jul 1, 2017	Sep 30, 2017	10-K	2019-03-18
Q2 2017		-$4.06M			Apr 1, 2017	Jun 30, 2017	10-K	2019-03-18
Q1 2017		-$3.36M			Jan 1, 2017	Mar 31, 2017	10-K	2019-03-18

* An asterisk sign (*) next to the value indicates that the value is likely invalid.